Lexaria BioscienceLEXX 
$3.22-1.23%24h
-1.23%24h
Global rank27489
Market cap$21.30M
Change 7d-7.20%
YTD Performance153.54%
SP500 benchmarkOutperform
P/E-3.19
P/S94.15
Revenue$226.21K
Earnings-$6.71M
Dividend yield-
Main Sector
Healthcare
Lexaria Bioscience (LEXX) Total Liabilities
LEXX Total Liabilities in 2022: $403.91K
According to Lexaria Bioscience latest financial reports the total liabilities of LEXX is $403.91K, an increase of 100.51% to 2022. At the end of 2022 company had $201.44K total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Lexaria Bioscience is responsible for during its operational activities.
Lexaria Bioscience (LEXX) Total Liabilities History from 2023 to 2022
-
Value:-
LEXX Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $403.91K | 100.51% |
| 2022 | $201.44K | -0.90% |
| 2021 | $203.26K | -41.25% |
| 2020 | $345.98K | 87.52% |
| 2019 | $184.51K | 415.60% |
| 2018 | $35.78K | - |
View the Top Total Liabilies Stocks
